Niagen Bioscinece (was ChromaDex)

NAD+ restoration, nicotinamide riboside, healthy aging

modulatingsmall molecule

niagenbioscience.com·Los Angeles, California, United States·Founded 1999·Public

01Overview 02People 03Projects 04Concepts 05Patents 06Public records 07Belief evolution

Plate C · C-ENBI

Summary · Eternal Search editorial

Niagen Bioscinece (was ChromaDex) NAD+ restoration, nicotinamide riboside, healthy aging

Niagen Bioscience describes itself as the global leader in NAD+ research and technology, with over 25 years of innovation. The company develops clinically researched NAD-enhancement solutions, including Niagen and Tru Niagen, and highlights patents, clinical studies, and global research collaborations. The site states that ChromaDex is now Niagen Bioscience.

The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →

Plate C·01 · Scientific profile

All 16 dimensions
on the record.

Composite27

Chain scale100 pts

Dimensions16

Plate C·02 · Where it sits among peers

Score vs. proximity
to longevity goals.

Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.

Reading

Niagen Bioscinece (was ChromaDex) — Translational · Lower middle. Derived deterministically from 4 extracted project(s). Most-advanced status: phase 1. Band: translational. Aging-relevance not LLM-reviewed in this pass.

Source: Deterministic

At a glance

Webniagenbioscience.com

HQLos Angeles, California, United States

Founded1999

StagePublic

Publications

13 on file

012026Preliminary Safety Analysis of Two Pilot Clinical Trials Involving ...medrxiv→022026Nutrition's role in extending healthspan: CRN-international symposium report.European journal of nutrition→032026A Framework for Developing Intake and Use Guidance for Dietary Supplement Bioactives.Advances in nutrition (Bethesda, Md.)→042024The Evolution of Science and Regulation of Dietary Supplements: Past, Present, and Future.The Journal of nutrition→052023Perspective: Council for Responsible Nutrition Science in Session. Optimizing Health with Nutrition-Opportunities, Gaps, and the Future.Advances in nutrition (Bethesda, Md.)→062022Potential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19.Journal of dietary supplements→072020Terms and nomenclature used for plant-derived components in nutrition and related research: efforts toward harmonization.Nutrition reviews→082020Determination of Select Nonvolatile Ginger Constituents in Dietary Ingredients and Finished Dosage Forms, First Action 2018.04.Journal of AOAC International→092019Pterostilbene raises low density lipoprotein cholesterol in people.Clinical nutrition (Edinburgh, Scotland)→102019Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults.Scientific reports→112016Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle.Cell metabolism→122016Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.Nature communications→

13—The Science of NAD+ in Aging Goes Deeper Than Blood—→

Loading

Loading section...

0-100 chain-logic scale · 15 dimensions · scored on public evidence

Niagen Bioscinece (was ChromaDex)

All 16 dimensionson the record.

Score vs. proximityto longevity goals.

Publications

Loading

All 16 dimensionson the record.

Score vs. proximityto longevity goals.

Publications

All 16 dimensions
on the record.

Score vs. proximity
to longevity goals.

All 16 dimensions
on the record.

Score vs. proximity
to longevity goals.